Youcare Pharmaceutical (SH:688658) 智通财经网·2025-12-02 08:24Core Viewpoint - Yuyuan Pharmaceutical (688658.SH) announced that its wholly-owned subsidiary, Beijing Yuyuan Ketech Pharmaceutical Technology Co., Ltd. (referred to as "Yuyuan Ketech"), has received approval from the National Medical Products Administration (NMPA) for two clinical trial approval notices regarding the YKYY018 aerosol inhalation agent for post-exposure prophylaxis in patients exposed to respiratory syncytial virus (RSV) and for the treatment of RSV infections [1] Group 1 - The company has obtained two clinical trial approval notices from NMPA for YKYY018 [1] - The clinical trials will focus on post-exposure prophylaxis and treatment of RSV infections [1] - The company plans to initiate Phase I clinical trials for the product [1]